Draegerwerk Ag & Co. Kgaa · XETR:DRW8

Draegerwerk Ag & Co. Kgaa — Drägerwerk AG & Co. KGaA — Q1 2026 Earnings Presentation

16 slides from Draegerwerk Ag & Co. Kgaa's earnings presentation, Apr 30, 2026

  1. Slide 1: Q1 Conference Call

    Q1 Conference Call Drägerwerk AG & Co. KGaA April 30, 2026, Lübeck

  2. Slide 2: Disclaimer

    Disclaimer — This presentation does not constitute an offer of securities for sale or a solicitation of an offer to purchase any securities. No money, securities or other consideration is being solicited by this presentation. This presentation contains forward-looking statements regarding the future

  3. Slide 3: Agenda

    Agenda — 01 Dräger Business Highlights 02 Financials Q1 2026 03 Outlook FY 2026 Drägerwerk AG & Co. KGaA 3

  4. Slide 4: Dräger Business Highlights

    01 Dräger Business Highlights Drägerwerk AG & Co. KGaA 4

  5. Slide 5: Q1 2026 Highlights

    Q1 2026 Return to net sales growth and Cash flow and margin significant increase in earnings considerably improved Highlights Continued good demand: order intake above the high prior-year level, mainly due to significant increase in Germany Net sales EBIT 755.9 million EUR 17.9 million Positive net

  6. Slide 6: Financials Q1 2026

    02 Financials Q1 2026 Drägerwerk AG & Co. KGaA 6

  7. Slide 7: Business development Group

    Business development Group Order entry Q1 2025 Q1 2026 Change — (€ million) (fx-adj.) Germany 196.4 219.1 +11.6 EMEA 355.3 356.3 +0.9 Net sales (€ million) Americas 172.4 162.6 +1.3 +6.9% APAC 136.8 126.7 +0.9 fx-adj +3.5% Total 860.8 864.7 +3.4 nominal 730 756 • Order entry above high prior-year le

  8. Slide 8: Business development Medical

    Business development Medical Order entry Q1 2025 Q1 2026 Change — (€ million) (fx-adj.) Germany 105.6 118.2 +11.9 EMEA 176.0 181.7 +4.7 Net sales (€ million) Americas 104.9 99.1 +1.3 +5.4% APAC 87.3 80.9 +2.5 fx-adj +1.1% Total 473.7 479.9 +5.2 nominal 413 418 • Order entry clearly higher due to goo

  9. Slide 9: Business development Safety

    Business development Safety Order entry Q1 2025 Q1 2026 Change — (€ million) (fx-adj.) Germany 90.8 100.9 +11.1 EMEA 179.3 174.6 -2.9 Net sales (€ million) Americas 67.5 63.6 +1.3 +8.8% APAC 49.6 45.8 -2.1 fx-adj +6.6% Total 387.1 384.8 +1.2 nominal 317 338 • Order entry slightly above prior-year le

  10. Slide 10: Key figures

    Key figures Q1 2026 Q1 2025 Change € million € million % Cash flow (from operating activities) 62.0 55.9 +10.9 Investments 32.7 28.9 +13.3 Free cash flow 44.1 32.0 +37.8 Cash and cash equivalents1 269.1 249.6 +7.8 Net financial debt1 85.5 141.8 -39.7 Net financial debt1 / EBITDA2 0.2 0.4 Capital emp

  11. Slide 11: Outlook FY 2026

    03 Outlook FY 2026 Drägerwerk AG & Co. KGaA 11

  12. Slide 12: Outlook

    Outlook Results achieved Forecast for for fiscal year 2025 fiscal year 2026 Net sales (net of currency effects) 5.3% 2.0 to 6.0% EBIT margin 6.7% 5.0 to 7.5% Dräger Value Added (DVA) EUR 90.1 million EUR 20 to 120 million Drägerwerk AG & Co. KGaA 12

  13. Slide 13: Questions & Answers

    Questions & Answers Drägerwerk AG & Co. KGaA 13

  14. Slide 14: Financial calendar

    Financial calendar Dräger publishes preliminary results approximately 2 weeks before the dates of the quarterly reports. Preliminary results for the full year are published in January. March 24, 2026 Annual Report 2025 Analysts‘ conference April 30, 2026 Report for the first three months 2026 Confer

  15. Slide 15: Contact

    Contact Visit our Investor Relations website: https://www.draeger.com/en-us_us/Investor-Relations Thomas Fischler | Head of Treasury & Investor Relations Moislinger Alle 53-55 23558 Lübeck, Germany Tel. +49 451 882 2685 Mail: thomas.fischler@draeger.com Nikolaus Hammerschmidt | Investor Relations Ma

  16. Slide 16: Thank you

    Thank you Drägerwerk AG & Co. KGaA 16

Drägerwerk AG & Co. KGaA — Q1 2026 Earnings Presentation on 6ix